Scarica l'app Stockscreener
66.51
1.35%
-0.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Precedente Chiudi:
$67.42
Aprire:
$65.84
Volume 24 ore:
2.21M
Relative Volume:
0.92
Capitalizzazione di mercato:
$8.29B
Reddito:
$692.26M
Utile/perdita netta:
$-512.41M
Rapporto P/E:
-15.69
EPS:
-4.24
Flusso di cassa netto:
$-274.36M
1 W Prestazione:
+4.86%
1M Prestazione:
+60.57%
6M Prestazione:
+56.31%
1 anno Prestazione:
+160.01%
Intervallo 1D:
$64.48
$68.00
Intervallo di 1 settimana:
$63.28
$68.00
Portata 52W:
$20.14
$68.00
Guardant Health Inc Stock (GH) Company Profile
Nome
Guardant Health Inc
Settore
Industria
Telefono
855-698-8887
Indirizzo
3100 HANOVER STREET, PALO ALTO
Confronta GH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
66.51 | 8.41B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-28 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-27 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-03-09 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-11-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Iniziato | Craig Hallum | Buy |
| 2022-10-06 | Iniziato | Stephens | Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | Piper Sandler | Overweight |
| 2022-04-28 | Ripresa | BTIG Research | Buy |
| 2022-02-24 | Reiterato | Canaccord Genuity | Buy |
| 2022-02-24 | Reiterato | Citigroup | Buy |
| 2022-02-24 | Reiterato | Cowen | Outperform |
| 2022-02-24 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-24 | Reiterato | SVB Leerink | Outperform |
| 2022-02-24 | Reiterato | Stifel | Buy |
| 2022-02-24 | Reiterato | Wells Fargo | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-11 | Iniziato | Stifel | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-06-12 | Iniziato | BTIG Research | Buy |
| 2020-02-21 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-08-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-16 | Iniziato | Canaccord Genuity | Buy |
| 2019-04-10 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Reiterato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | JP Morgan | Overweight |
| 2018-10-29 | Iniziato | William Blair | Outperform |
Mostra tutto
Guardant Health Inc Borsa (GH) Ultime notizie
Is Guardant Health Inc. showing signs of accumulationEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Guardant Health Inc. stock daily chart insightsPortfolio Profit Report & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - PR Newswire
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Will Guardant Health Inc. see short term momentumTrade Volume Summary & Growth Focused Stock Reports - Newser
What’s the analyst consensus on Guardant Health Inc.Rate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
How to read the order book for Guardant Health Inc.Market Growth Report & Risk Managed Investment Entry Signals - Newser
Is Guardant Health Inc. impacted by rising ratesQuarterly Profit Review & Smart Money Movement Alerts - خودرو بانک
Multi asset correlation models including Guardant Health Inc.2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
Will Guardant Health Inc. bounce back from current supportJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
What to do if you’re stuck in Guardant Health Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Live market analysis of Guardant Health Inc.Dividend Hike & Stepwise Swing Trade Plans - Newser
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Market Mood & High Yield Stock Recommendations - Newser
Guardant Health Inc. stock prediction for this weekTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Using flow based indicators on Guardant Health Inc.Weekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
Will Guardant Health Inc. Bounce From 52 Week Low getLinesFromResByArray error: size == 0 - thegnnews.com
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Guardant Health Inc. stock outlook for YEARForecast Cut & Expert Curated Trade Setup Alerts - Newser
Will Guardant Health Inc. stock recover after recent drop2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Guardant Health’s Strategic Moves and Analyst Confidence Propel Market Potential - StocksToTrade
Technical signs of recovery in Guardant Health Inc.2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Can machine learning forecast Guardant Health Inc. recoveryEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Backtesting results for Guardant Health Inc. trading strategiesPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Is Guardant Health Inc. stock showing strong momentumWeekly Trading Summary & Expert Approved Trade Ideas - sundaytimes.kr
Will Guardant Health Inc. price bounce be sustainableInsider Selling & High Win Rate Trade Tips - Newser
Guardant Health Shares Jump 4.58% on Q2 Revenue Growth Product Expansion and Analyst Upgrades Trading Volume Ranks 495th - AInvest
Guardant Health Inc Azioni (GH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):